The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.
Three regions of the human Hageman factor molecule termed the c, d, and e regions have been defined. Division of the molecule into these three regions is based on the analysis of fragments obtained by enzymatic cleavage during fluid-phase activation. The three regions have the following properties: (a) the c region has a mol wt of 40,000, has the capacity to bind to negatively charged surfaces, and does not have detectable enzymatic activity; (b) the e region possess a mol wt of 28,000 has enzymatic activity, and does not bind to negatively charged surfaces; (c) the d region has a mol wt of 12,000, is located between the c and e fragments but has not been detected as a freely existing polypeptide, and can bind firmly to negatively charged surfaces. The preparation of antibodies specific for the c and e regions is described as well as their use in defining the electrophoretic characteristics of the cde, cd, de, c, and e polypeptide fragments of Hageman factor. Evidence is given showing that the e region, but not the c or d, is released from a negatively charged surface when bound Hageman factor is exposed to proteolytic enzymes or whole plasma and that when this occurs in the presence of normal plasma, the e fragment becomes bound to C1 esterase inhibitor.
D004586:Electrophoresis; D005174:Factor XII / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007122:Immunoelectrophoresis; D007457:Iodine Radioisotopes; D007610:Kallikreins / Q000494:pharmacology; D007616:Kaolin / Q000378:metabolism; D008970:Molecular Weight; D011288:Prekallikrein / Q000494:pharmacology; D013329:Structure-Activity Relationship
D007457:Iodine Radioisotopes; D007616:Kaolin; D005174:Factor XII; D011288:Prekallikrein; D007610:Kallikreins